Manon Ros

Manon Ros

Auto-generated profile, based on publicly available information

Manon Ros

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SSSimon Schwörer
Simon Schwörer
FCFrancesco V. Cimino
Francesco V. Cimino
MRManon Ros
Manon Ros
KTKaloyan M. Tsanov
Kaloyan M. Tsanov
CNCharles Ng
Charles Ng
CTCraig B. Thompson
Craig B. Thompson
Cancer-associated fibroblasts (CAF) are a major cell type in the stroma of solid tumors and can exert both tumor-promoting and tumor-restraining functions. CAF heterogeneity is frequently observed in pancreatic ductal adenocarcinoma (PDAC), a tumor characterized by a dense and hypoxic stroma that features myofibroblastic CAFs (myCAF) and inflammatory CAFs (iCAF) that are thought to have opposing roles in tumor progression. While CAF heterogeneity can be driven in part by tumor cell–produced cytokines, other determinants shaping CAF identity and function are largely unknown. In vivo, we found that iCAFs displayed a hypoxic gene expression and biochemical profile and were enriched in hypoxic regions of PDAC tumors, while myCAFs were excluded from these regions. Hypoxia led fibroblasts to acquire an inflammatory gene expression signature and synergized with cancer cell–derived cytokines to promote an iCAF phenotype in a HIF1α-dependent fashion. Furthermore, HIF1α stabilization was sufficient to induce an iCAF phenotype in stromal cells introduced into PDAC organoid cocultures and to promote PDAC tumor growth. These findings indicate hypoxia-induced HIF1α as a regulator of CAF heterogeneity and promoter of tumor progression in PDAC. Significance: Hypoxia in the tumor microenvironment of pancreatic cancer potentiates the cytokine-induced inflammatory CAF phenotype and promotes tumor growth. See related commentary by Fuentes and Taniguchi, p. 1560

1 November 2017 in Cancer Cell
Verified
Journal Article
Closed access
ANAnh Tuan Nguyen
Anh Tuan Nguyen
JCJoanne Chia
Joanne Chia
MRManon Ros
Manon Ros
KHKam Man Hui
Kam Man Hui
FSFrederic Saltel
Frederic Saltel
FBFrederic Bard
Frederic Bard

8 June 2018 in Cell Adhesion & Migration
Verified
Journal Article
Closed access
EHElodie Henriet
Elodie Henriet
MSMargaux Sala
Margaux Sala
AHAya Abou Hammoud
Aya Abou Hammoud
ATAdjanie Tuariihionoa
Adjanie Tuariihionoa
JMJulie Di Martino
Julie Di Martino
FSFrédéric Saltel
Frédéric Saltel
Discoidin domain receptors, DDR1 and DDR2, are two members of collagen receptor family that belong to tyrosine kinase receptor subgroup. Unlike other matrix receptor-like integrins, these collagen receptors have not been extensively studied. However, more and more studies are focusing on their involvement in cancer. These two receptors are present in several subcellular localizations such as intercellular junction or along type I collagen fibers. Consequently, they are involved in multiple cellular functions, for instance, cell cohesion, proliferation, adhesion, migration and invasion. Furthermore, various signaling pathways are associated with these multiple functions. In this review, we highlight and characterize hallmarks of cancer in which DDRs play crucial roles. We discuss recent data from studies that demonstrate the involvement of DDRs in tumor proliferation, cancer mutations, drug resistance, inflammation, neo-angiogenesis and metastasis. DDRs could be potential targets in cancer and we conclude this review by discussing the different ways to inhibits them.

19 February 2025 in Nature
Verified
Journal Article
Open access
PDF file
GGGizem Guzelsoy
Gizem Guzelsoy
SESetiembre D. Elorza
Setiembre D. Elorza
MRManon Ros
Manon Ros
LSLogan T. Schachtner
Logan T. Schachtner
MHMakiko Hayashi
Makiko Hayashi
CCCarlos Carmona-Fontaine
Carlos Carmona-Fontaine
The survival of malignant cells within tumours is often seen as depending on ruthless competition for nutrients and other resources1,2. Although competition is certainly critical for tumour evolution and cancer progression, cooperative interactions within tumours are also important, albeit poorly understood3,4. Cooperative populations at all levels of biological organization risk extinction if their population size falls below a critical tipping point5,6. Here we examined whether cooperation among tumour cells may be a potential therapeutic target. We identified a cooperative mechanism that enables tumour cells to proliferate under the amino acid-deprived conditions found in the tumour microenvironment. Disruption of this mechanism drove cultured tumour populations to the critical extinction point and resulted in a marked reduction in tumour growth in vivo. Mechanistically, we show that tumour cells collectively digest extracellular oligopeptides through the secretion of aminopeptidases. The resulting free amino acids benefit both aminopeptidase-secreting cells and neighbouring cells. We identified CNDP2 as the key enzyme that hydrolyses these peptides extracellularly, and loss of this aminopeptidase prevents tumour growth in vitro and in vivo. These data show that cooperative scavenging of nutrients is key to survival in the tumour microenvironment and reveal a targetable cancer vulnerability.

1 August 2020 in Developmental Cell
Verified
Journal Article
Closed access
MRManon Ros
Manon Ros
MSMargaux Sala
Margaux Sala
FSFrédéric Saltel
Frédéric Saltel

17 October 2024 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
LVLibi Anandi Viswanathan
Libi Anandi Viswanathan
JGJeremy Garcia
Jeremy Garcia
MRManon Ros
Manon Ros
LJLibuše Janská
Libuše Janská
JLJosephine Liu
Josephine Liu
CCCarlos Carmona-Fontaine
Carlos Carmona-Fontaine
Ischemic conditions such as hypoxia and nutrient starvation, together with interactions with stromal cells, are critical drivers of metastasis. These conditions arise deep within tumor tissues, and thus, observing nascent metastases is exceedingly challenging. We thus developed the 3MIC—an ex vivo model of the tumor microenvironment—to study the emergence of metastatic features in tumor cells in a 3-dimensional (3D) context. Here, tumor cells spontaneously create ischemic-like conditions, allowing us to study how tumor spheroids migrate, invade, and interact with stromal cells under different metabolic conditions. Consistent with previous data, we show that ischemia increases cell migration and invasion, but the 3MIC allowed us to directly observe and perturb cells while they acquire these pro-metastatic features. Interestingly, our results indicate that medium acidification is one of the strongest pro-metastatic cues and also illustrate using the 3MIC to test anti-metastatic drugs on cells experiencing different metabolic conditions. Overall, the 3MIC can help dissecting the complexity of the tumor microenvironment for the direct observation and perturbation of tumor cells during the early metastatic process.